abstract |
Problem: to obtain a compound used as a new agent, which is excellent for the prevention and / or treatment of diseases associated with type 2 cannabinoid receptor, based on the agonistic action of type 2 cannabinoid receptor. Solution: a study was conducted of compounds having an agonist effect on type 2 cannabinoid receptor, and it was confirmed that the fused ring pyridine compound in accordance with this invention has an excellent agonistic effect on type 2 cannabinoid receptor. Such a fused ring pyridine compound has an agonist effect on type 2 cannabinoid receptor and can be used as a prophylactic and / or therapeutic agent for diseases related to type 2 cannabinoid receptor, such as inflammatory diseases and pain. |